Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Gamma-Aminobutyric Acid and Ng-Nitroarginine Methyl Ester

Research Papers that Mention the Interaction

But in the presence of L-NAME , a nitric oxide synthesis inhibitor, although GABA- induced vasorelaxation was not suppressed at a dose of 1 µM of GABA in all groups, this response was suppressed with the other doses of GABA.
General physiology and biophysics  •  2013  |  View Paper
Both the inhibitory and excitatory effects of GABA were blocked by TTX and L-NAME + apamin; the GABA-induced contraction was also sensitive to L 732-138.
Life sciences  •  2002  |  View Paper
An NO decreasing dose of nitric oxide synthase (NOS) inhibitor, N-nitro-L-arginine methyl ester (L-NAME) decreased brain GABA concentration and increased the convulsant action of picrotoxin.
Pharmacology Biochemistry and Behavior  •  2002  |  View Paper
Our findings tend to indicate that the change of behavioral state observed after systemic or intra-DRN administration of L-NAME is partly related to the reduction of GABA and adenosine at critical sites in the CNS.
Behavioural Brain Research  •  2001  |  View Paper
L-NMMA (0.3 mM) and L-NAME (0.5 mM) increased K(+)-evoked GABA release, indicating that NO plays an inhibitory role in GABA release from PP.
The inhibition in both basal and K(+)-evoked GABA release induced by NKA (10(-7) M) was reduced by L-NAME (1 mM).
Brain Research Bulletin  •  2000  |  View Paper
The NOS inhibitors L-NAME and L-NOARG reduced in a concentration-dependent manner nerve-mediated relaxations elicited by TES, nicotine and GABA.
Journal of autonomic pharmacology  •  1999  |  View Paper
1.0 mM L-NAME significantly decreased basal extracellular GABA , while abolishing the NMDA-evoked release of the amino acid.
The nitric oxide synthase inhibitor L-nitro-arginine-methyl ester (L-NAME; 100 microM) increased basal GABA release, and also enhanced release of GABA evoked by NMDA (100 microM) compared with the same concentration of NMDA infused alone.
Brain Research  •  1996  |  View Paper
The inhibitor of L-arginine-NO synthase N omega-Nitro-L-arginine methyl ester L-NAME ) (10(-4)-3 x 10(-4) M) reduced the NANC relaxations elicited by GABA and low frequency electrical stimulation in a dose-dependent manner.
Journal of autonomic pharmacology  •  1996  |  View Paper
On the other hand, NO seems to be involved in the inhibitory effect of GABA on prolactin release since hemoglobin, a scavenger of NO, and Nw‐nitro‐L‐arginine methyl ester , an inhibitor of NO synthase (NOS), blocked the pituitary response to GABA.
Journal of neuroendocrinology  •  1996  |  View Paper